The move comes as Philips has agreed to a consent decree with the Food and Drug Administration and the Department of Justice that could cost the company nearly $400 million. In June 2021, Philips ...
The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the manufacturer nearly ...
Three years after one of the largest medical device recalls in history, the fallout – health-wise and financial – continues to impact many patients with sleep apnea. Now a critical deadline is ...
The U.S. Food and Drug Administration has updated a recall affecting millions of Philips sleep apnea machines, now saying that they may been linked to at least 561 deaths. The agency, in a statement ...
Add Yahoo as a preferred source to see more of our stories on Google. Philips said Monday it will stop selling its sleep apnea machines in the US, more than two years after the Dutch manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results